New Ca2+ agonist (Bay K 8644) enhances and induces cardiac slow action potentials
G. M. Wahler and N. Sperelakis Bay K 8644 is an analogue of nifedipine that has positive inotropic and vasoconstricting actions and was postulated to be a Ca agonist (i.e., a Ca2+-channel activator). To test this hypothesis, we examined the electrophysiological effects of this compound in isolated g...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Heart and circulatory physiology 1984-08, Vol.247 (2), p.H337-H340 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | G. M. Wahler and N. Sperelakis
Bay K 8644 is an analogue of nifedipine that has positive inotropic and
vasoconstricting actions and was postulated to be a Ca agonist (i.e., a
Ca2+-channel activator). To test this hypothesis, we examined the
electrophysiological effects of this compound in isolated guinea pig
papillary muscles. Bay K 8644 (10(-6) M) had little effect on the normal
fast action potentials, although it did increase contractility. Bay K 8644
did, however, induce Ca2+-dependent slow action potentials (fast Na+
channels inactivated by 25 mM K+). When slow action potentials had been
previously induced by tetraethylammonium chloride (10 mM) plus Ca2+ (4.0
mM) or isoproterenol (2 X 10(-7) M), 10(-6) M Bay K 8644 potentiated the
slow action potentials, i.e., increased their maximal rate of rise (Vmax),
concomitant with its positive inotropic effect. All effects of Bay K 8644
could be reversed by 10(-6) M nifedipine. Thus it appears that Bay K 8644
enhances Ca2+ influx through the myocardial slow channels, consistent with
the concept that Bay K 8644 is a Ca2+-channel stimulator. |
---|---|
ISSN: | 0363-6135 0002-9513 1522-1539 |
DOI: | 10.1152/ajpheart.1984.247.2.H337 |